Palla Pharma Ltd
ASX:PAL

Watchlist Manager
Palla Pharma Ltd Logo
Palla Pharma Ltd
ASX:PAL
Watchlist
Price: 0.295 AUD
Market Cap: 47.8m AUD

Palla Pharma Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Palla Pharma Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Palla Pharma Ltd
ASX:PAL
Cash from Operating Activities
-AU$22.7m
CAGR 3-Years
-36%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Anteotech Ltd
ASX:ADO
Cash from Operating Activities
-AU$5.8m
CAGR 3-Years
12%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Proteomics International Laboratories Ltd
ASX:PIQ
Cash from Operating Activities
-AU$6.6m
CAGR 3-Years
-23%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
T
Trajan Group Holdings Ltd
ASX:TRJ
Cash from Operating Activities
AU$10.8m
CAGR 3-Years
58%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Genetic Signatures Ltd
ASX:GSS
Cash from Operating Activities
-AU$12.3m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
N/A
E
EZZ Life Science Holdings Ltd
ASX:EZZ
Cash from Operating Activities
AU$4.4m
CAGR 3-Years
32%
CAGR 5-Years
8%
CAGR 10-Years
N/A
No Stocks Found

Palla Pharma Ltd
Glance View

Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.

PAL Intrinsic Value
Not Available

See Also

What is Palla Pharma Ltd's Cash from Operating Activities?
Cash from Operating Activities
-22.7m AUD

Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Cash from Operating Activities amounts to -22.7m AUD.

What is Palla Pharma Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-7%

Over the last year, the Cash from Operating Activities growth was -174%. The average annual Cash from Operating Activities growth rates for Palla Pharma Ltd have been -36% over the past three years , -7% over the past five years .

Back to Top